TargetMol

Norepinephrine bitartrate salt

Product Code:
 
TAR-T21066
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T21066-5mg5mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21066-1mL1 mL * 10 mM (in DMSO)£120.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21066-10mg10mg£127.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21066-25mg25mg£162.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21066-50mg50mg£205.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21066-100mg100mg£270.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Norepinephrine bitartrate salt is an adrenergic neurotransmitter.
CAS:
3414-63-9
Formula:
C13H19NO8
Molecular Weight:
317.294
Pathway:
Neuroscience; GPCR/G Protein
Purity:
0.9997
SMILES:
C[C@H]([C@@H](O)C(O)=O)C(O)=O.NCC(O)c1ccc(O)c(O)c1
Target:
Adrenergic Receptor

References

1. Haiying Shen, Feng Qu, Yong Xia, et al.Straightforward and Ultrastable Surface Modification of Microfluidic Chips with Norepinephrine Bitartrate Improves Performance in Immunoassays. Anal Chem. 2018 Mar 20;90(6):3697-3702. 2. Mody V , Patel J , Shah S , et al. Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration[J]. International Journal of Pharmaceutical Compounding, 2016, 20(3):236.